Based on Network Pharmacology to Explore the Potential Bioactive Compounds and Mechanisms of Zuojin Pill for the Treatment of Ulcerative Colitis

Background Zuojin Pill (ZJP), a classic prescription, has the potential to prevent ulcerative colitis (UC). However, the active components and mechanisms of ZJP are still arcane. This study aimed to use a network pharmacology approach to find the bioactive compounds and potential action mechanisms of ZJP in the treatment of UC. Methods Firstly, the components and putative targets of ZJP were collected based on herbal medicine target databases, and a network containing the interaction between the targets of ZJP and the potential therapeutic targets of UC was established. Then, topological parameters were calculated to identify the key targets in the network and, in turn, to import them into the David database to perform path enrichment analysis. Results 14 potential therapeutic components of ZJP and 26 key targets were obtained. These targets were related to signal transduction, MAPK cascade, inflammatory response, immune response, and the apoptotic process of UC. Moreover, the PI3K-Akt signaling pathway, MAPK signaling pathway, toll-like receptor signaling pathway, and Prolactin signaling pathway were predicted to participate in ZJP treating UC. Among them, 14 active components of ZJP directly regulate these pathways. Conclusion ZJP could alleviate UC through the predicted components and mechanisms. The 14 predicted active components of ZJP may mainly play a therapeutic role for UC through synergistic regulation of the PI3K-Akt signaling pathway and MAPK signaling pathway.

[1]  W. Shen,et al.  Worenine reverses the Warburg effect and inhibits colon cancer cell growth by negatively regulating HIF-1α , 2021, Cellular & molecular biology letters.

[2]  Jin Wang,et al.  A protocol for systematic review and meta-analysis , 2020 .

[3]  L. Llamado,et al.  Epidemiology, burden of disease, and unmet needs in the treatment of ulcerative colitis in Asia , 2020, Expert review of gastroenterology & hepatology.

[4]  Bu-Gao Zhou,et al.  Regulatory effect of Zuojin Pill on correlation with gut microbiota and Treg cells in DSS-induced colitis. , 2020, Journal of ethnopharmacology.

[5]  W. Niu,et al.  Kuijieyuan Decoction Improved Intestinal Barrier Injury of Ulcerative Colitis by Affecting TLR4-Dependent PI3K/AKT/NF-κB Oxidative and Inflammatory Signaling and Gut Microbiota , 2020, Frontiers in Pharmacology.

[6]  Yaru Zhang,et al.  Effect of epiberberine from Coptis chinensis Franch on inhibition of tumor growth in MKN-45 xenograft mice. , 2020, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[7]  Zhengtao Wang,et al.  Obacunone Protects Against Ulcerative Colitis in Mice by Modulating Gut Microbiota, Attenuating TLR4/NF-κB Signaling Cascades, and Improving Disrupted Epithelial Barriers , 2020, Frontiers in Microbiology.

[8]  X. Qin,et al.  Exploration the active compounds of Astragali Radix in treatment of adriamycin nephropathy by network pharmacology combined with transcriptomic approach. , 2020, Journal of ethnopharmacology.

[9]  Yuhong Liu,et al.  Anti-Inflammatory Effects of Huangqin Decoction on Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice Through Regulation of the Gut Microbiota and Suppression of the Ras-PI3K-Akt-HIF-1α and NF-κB Pathways , 2020, Frontiers in Pharmacology.

[10]  M. Farzaei,et al.  Targeting Mitogen-Activated Protein Kinases by Natural Products: A Novel Therapeutic Approach for Inflammatory Bowel Diseases. , 2019, Current pharmaceutical biotechnology.

[11]  Jing Zhao,et al.  Network pharmacology-based identification for therapeutic mechanism of Ling-Gui-Zhu-Gan decoction in the metabolic syndrome induced by antipsychotic drugs , 2019, Comput. Biol. Medicine.

[12]  W. Lu,et al.  β‐Sitosterol improves experimental colitis in mice with a target against pathogenic bacteria , 2018, Journal of cellular biochemistry.

[13]  Z. Su,et al.  Palmatine attenuated dextran sulfate sodium (DSS)‐induced colitis via promoting mitophagy‐mediated NLRP3 inflammasome inactivation , 2019, Molecular immunology.

[14]  Rui Gao,et al.  Network pharmacology-based identification of protective mechanism of Panax Notoginseng Saponins on aspirin induced gastrointestinal injury. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[15]  Fengbin Liu,et al.  Development of a Traditional Chinese Medicine Syndrome-Specific Scale for Ulcerative Colitis: The Large Intestine Dampness-Heat Syndrome Questionnaire , 2018, Evidence-based complementary and alternative medicine : eCAM.

[16]  J. Colombel,et al.  Systematic review: safety of mesalazine in ulcerative colitis , 2018, Alimentary pharmacology & therapeutics.

[17]  Jianping Chen,et al.  Berberrubine attenuates mucosal lesions and inflammation in dextran sodium sulfate-induced colitis in mice , 2018, PloS one.

[18]  D. Luo,et al.  [Therapeutic effects of rutaecarpine on dextran sodium sulfate-induced experimental colitis in mice]. , 2018, Zhonghua yi xue za zhi.

[19]  S. Habtemariam,et al.  Natural Therapies of the Inflammatory Bowel Disease: The Case of Rutin and its Aglycone, Quercetin. , 2018, Mini reviews in medicinal chemistry.

[20]  Arvin Haj‐Mirzaian,et al.  Role of toll‐like receptors in inflammatory bowel disease , 2017, Pharmacological research.

[21]  J. Raiyn,et al.  Nature is the best source of anti-inflammatory drugs: indexing natural products for their anti-inflammatory bioactivity , 2017, Inflammation Research.

[22]  Zhi-hong Li,et al.  Synthesis and Structure-Activity Relationships of Quaternary Coptisine Derivatives as Potential Anti-ulcerative Colitis Agents. , 2015, Journal of medicinal chemistry.

[23]  S. Kortagere,et al.  Plant flavonol isorhamnetin attenuates chemically induced inflammatory bowel disease via a PXR-dependent pathway. , 2014, The Journal of nutritional biochemistry.

[24]  R. Gearry,et al.  Use and Predictors of Oral Complementary and Alternative Medicine by Patients With Inflammatory Bowel Disease: A Population-Based, Case–Control Study , 2013, Inflammatory bowel diseases.

[25]  M. Silverberg,et al.  Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease , 2012, Alimentary Pharmacology and Therapeutics.

[26]  M. Talamini,et al.  Ulcerative colitis , 2012, The Lancet.

[27]  Hong Shen,et al.  Clinical observations on 100 cases of ulcerative colitis treated with the method of clearing away heat, expelling dampness, promoting blood circulation and healing ulcer. , 2010, Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan.